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Abstract
Rationale: Pooling data from multiple cohorts and extending the
time frame across childhood should minimize study-speciﬁc effects,
enabling better characterization of childhood wheezing.
Objectives: To analyze wheezing patterns from early childhood to
adolescence using combined data from ﬁve birth cohorts.
Methods: We used latent class analysis to derive wheeze phenotypes
among 7,719 participants from ﬁve birth cohorts with complete report
of wheeze at ﬁve time periods. We tested the associations of derived
phenotypes with late asthma outcomes and lung function, and
investigated the uncertainty in phenotype assignment.
Results: We identiﬁed ﬁve phenotypes: never/infrequent wheeze
(52.1%), early onset preschool remitting (23.9%), early onset
midchildhood remitting (9%), persistent (7.9%), and late-onset
wheeze (7.1%). Compared with the never/infrequent wheeze, all
phenotypes had higher odds of asthma and lower forced expiratory
volume in 1 second and forced expiratory volume in 1 second/forced
vital capacity in adolescence. The association with asthma was
strongest for persistent wheeze (adjusted odds ratio, 56.54; 95%
conﬁdence interval, 43.75–73.06). We observed considerable within-
class heterogeneity at the individual level, with 913 (12%) children
having low membership probability (,0.60) of any phenotype.
Class membership certainty was highest in persistent and
never/infrequent, and lowest in late-onset wheeze (with 51% of
participants having membership probabilities ,0.80). Individual
wheezing patterns were particularly heterogeneous in late-onset
wheeze, whereas many children assigned to early onset preschool
remitting class reported wheezing at later time points.
Conclusions: All wheeze phenotypes had signiﬁcantly diminished
lung function in school-age children, suggesting that the notion that
early life episodic wheeze has a benign prognosis may not be true for
a proportion of transient wheezers. We observed considerable
within-phenotype heterogeneity in individual wheezing patterns.
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Wheezing is one of the most common
symptoms in infants and young children.
Childhood wheezing is highly
heterogeneous (1–4), and distinguishing
subtypes of wheezing and their underlying
mechanisms is a prerequisite to develop
interventions to target children whose
wheezing persists, while avoiding
overtreatment of transient wheeze (5).
Over the last two decades, substantial
effort has been devoted to understanding the
heterogeneity of childhood wheezing (5–9).
In a pioneering study using clinical insights
about the age of onset, progression, and
remission of wheezing, Martinez and
coworkers (1) described three mutually
exclusive wheezing phenotypes (transient
early, late-onset, and persistent). These
ﬁndings were conﬁrmed in several
independent cohorts (4, 10, 11).
Subsequently, the approach to discovering
longitudinal wheezing phenotypes was
extended to data-driven approaches, such as
the latent class analysis (LCA), which
suggested the existence of one or two (12)
further intermediate phenotypes. However,
although phenotypes derived using LCA in
different studies are usually designated with
the same name, they often differ in temporal
trajectories, distributions within a
population, and associated risk factors (9).
This is in part a consequence of the
study characteristics, including sample
size and the timing and frequency of data
collection (8).
A further reason may arise from the
heterogeneity between children within
each phenotype, which has seldom been
investigated. For example, in most LCA
models, there are individuals who cannot be
classiﬁed with a high degree of certainty.
Latent class model estimates class
membership probabilities (each individual’s
probability of membership of each class),
which are traditionally used to assign
individuals to the latent class with the highest
posterior probability (13–15).
Such maximum-probability phenotype
assignment is equivalent to ﬁxing individuals’
membership probabilities of their highest
phenotype to 1 and all others to 0, and may
introduce within-class heterogeneity.
Therefore, models that are weighted for the
probability of each subject belonging to each
phenotype should be used to compensate for
uncertainty in phenotype assignment (3, 16).
We propose that pooling data from
multiple birth cohorts and extending the time
frame from early childhood to adolescence
should minimize study-speciﬁc effects,
thereby enabling us to better understand the
true variation in the natural history of
wheezing, and the individual differences
within apparently homogeneous phenotypes.
We therefore proceeded to analyze wheezing
patterns from early childhood to adolescence/
young adulthood using combined data from
ﬁve birth cohorts in the U.K. STELAR
consortium (6), and their associations with
early life risk factors, asthma-related
outcomes, and lung function measures in late
childhood. We then investigated the extent of
uncertainty in phenotype assignment, and
individual variations in wheezing within and
across phenotypes.
We acknowledge that the wheeze
classes discovered using data-driven
approaches are not observed but are
latent by nature, and ideally should not be
referred to as “phenotypes” (i.e., observable
characteristics); however, because the term
“phenotype” has been used in this context
for more than a decade, we maintain this
nomenclature in this manuscript.
Methods
Study Design, Setting, and
Participants
The STELAR consortium (6) brings
together ﬁve U.K. population-based birth
cohorts: Avon Longitudinal Study of Parents
and Children (ALSPAC) (17), Ashford
(ASHFORD) (18), and Isle of Wight (IOW)
(4, 19) cohorts; Manchester Asthma and
Allergy Study (MAAS) (20); and the
Aberdeen Study of Eczema and Asthma to
Observe the Effects of Nutrition (SEATON)
(21). The cohorts are described in detail in
the online supplement. All studies were
approved by research ethics committees.
Informed consent was obtained from
parents, and study subjects gave their assent/
consent when applicable. Data were
imported into a web-based knowledge
management platform, Asthma eLab
(www.asthmaelab.org) (6).
Data Sources and Deﬁnition of
Outcomes
Validated questionnaires were completed
on multiple occasions from infancy to
adolescence (14 time points in ALSPAC
over 16.5 yr, 7 in ASHFORD over 14 yr, 6 in
MAAS over 16 yr, 6 in SEATON over 14 yr,
and 5 in IOW over 18 yr). The cohort-
speciﬁc time points and sample size
included in this analysis are shown in Table
E1 in the online supplement. We used data
on current wheeze collected at proximate
time periods across cohorts: infancy (0.5–
1 yr), early childhood (2–3 yr), preschool/
early school age (4–5 yr), middle childhood
(8–10 yr), and adolescence (14–18 yr).
Current wheeze was deﬁned as a positive
response to the question “Has your child
had wheezing or whistling in the chest in the
last 12 months?” Deﬁnitions of other
variables are provided in the online
supplement (see Table E2).
Skin prick testing was performed at age
4 years in IOW; age 5 years in SEATON,
ASHFORD, and MAAS; and 7.5 years in
ALSPAC. Allergic sensitization was deﬁned
as a wheal diameter of 3 mm greater than the
negative control to one or more common
allergens.
We performed spirometry and
recorded forced expiratory volume in one
second (FEV1) and forced vital capacity
(FVC). To reduce variability, we restricted
our analyses to lung function measured at
comparable ages (8.5 yr in ALSPAC, 10 yr in
SEATON and IOW, and 11 yr in MAAS).
Statistical Analysis
A detailed description of statistical analysis
is presented in the online supplement.
Brieﬂy, we used LCA to identify longitudinal
trajectories of wheeze among 7,719 children
with complete data on wheezing at ﬁve time
periods. Cohort ID was included as an
additional covariate by transforming the
ﬁve-category variable into a set of four
dummy variables. The optimal number of
classes was selected based on the Bayesian
information criterion and interpretability.
We repeated analyses among 15,941
children with at least two observations, and
examined the stability of allocation of 7,719
children with complete data to their most
probable class when using a larger but
Supported by the Wellcome Trust Strategic Award (108,818/15/Z). STELAR consortium is funded by the UK Medical Research Council (Grants G0601361 and
MR/K002449/1). The U.K. Medical Research Council and the Wellcome Trust (Grant 102,215/2/13/2) and the University of Bristol provide core support for
ALSPAC.
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incomplete data set. We also assessed the
stability of the optimal number of classes
excluding the largest cohort, ALSPAC. To
understand how children are reassigned to
different phenotypes when the number of
phenotypes increases, we compared LCA
models constrained to four classes to models
with ﬁve classes.
We then examined the relationships of
the derived phenotypes with asthma and
asthma medication use at the latest follow-
up, and lung function (z scores for adjusted
FEV1, FVC, and FEV1/FVC) using logistic
regression models weighted for the
probability of each individual belonging to
each phenotype. Models were adjusted for
potential confounders, including allergic
sensitization (midchildhood), maternal
history of asthma/allergy, maternal
smoking, and low birth weight. We used
weighted multinomial logistic regression
models to ascertain early life risk factors
associated with each phenotype; results are
reported as relative risk ratios (RRR) with
95% conﬁdence intervals (CI).
We then investigated individual
variations in wheezing within and across
phenotypes. We deﬁned categories of class
membership certainty based on class
membership probabilities (high >0.80,
medium= 0.60–0.80, low,0.60) to elicit the
extent of within-class homogeneity in
different certainty thresholds. Analyses were
performed using Mplus 8, R (http://www.r‐
project.org/) and Stata 14 (StataCorp).
Results
Characteristics of the Study
Population
Of 7,719 children with complete data on
wheezing, 50.3% were male, 14.1% had
current asthma, and 13.4% reported using
asthma medication at the last available
follow-up. Mean (standard deviation) birth
weight in the combined dataset was 3.44 kg
(0.53), with 314 (4.1%) children having a
low birth weight (<2.5 kg); mean maternal
age at delivery was 29.1 years (standard
deviation, 4.64), and 1,198 (16%) mothers
reported smoking during pregnancy
(Table 1).
Wheeze Phenotypes from Infancy to
Adolescence and Transitions in
Phenotype Membership
A ﬁve-class solution was selected as the
optimal model based on statistical ﬁt (see
Table E3, see online supplement for more
details on model selection). Trajectories of
wheeze for each class are shown in Figure 1.
Based on the onset and duration of wheeze,
the classes were labeled as 1) never/
infrequent wheeze (52.1%); 2) early onset
preschool remitting wheeze (23.9%), with
50–60% prevalence of wheeze during
infancy, decreasing to 20% around early
childhood and to less than 10% afterward; 3)
early onset midchildhood remitting wheeze
(9%), with early onset and peak prevalence
(z75%) in preschool/early school age,
decreasing to 23% in midchildhood, and
diminishing further by adolescence; 4)
persistent wheeze (7.9%) with 53% wheeze
prevalence during infancy, and an
increasing prevalence thereafter to a high
prevalence of approximately 80%; and 5)
late-onset wheeze (7.1%) with a low
prevalence of 27% until preschool/early
school age, increasing rapidly to a peak
prevalence of 74% in adolescence.
Characteristics of children across different
phenotypes are presented in Table 1. LCA of
four cohorts with complete data (excluding
ALSPAC) provided very similar results.
Figure 2A shows the changes in the
allocation of 7,719 individuals with
complete data from the model using only
children with data on wheezing at all ﬁve
time periods to their most probable class in
the model using 15,941 individuals with at
least two observations. The optimal solution
in the model using 15,941 children
remained ﬁve classes (see Table E3, Figure
E1), and was very similar to that derived
from a complete data set. Never/infrequent
and persistent phenotype assignments were
very stable, but there were considerable
transitions between other classes (e.g., 39%
of children assigned to the early onset
midchildhood remitting wheeze using
complete data were assigned to persistent
wheeze in the model with incomplete data).
To understand how class allocation
changes in models with increasing number
of phenotypes, we compared LCA models
with four and ﬁve phenotypes using
complete data (Figure 2B). Never/
infrequent and late-onset phenotypes were
similar in both models. With the addition
of a ﬁfth phenotype, transient-early wheeze
divided into two remitting classes
(preschool and midchildhood resolution),
whereas a third of children from the
persistent wheeze in a four-class solution
transitioned, mainly to early onset
midchildhood remitting wheeze.
Wheeze Phenotypes, Family History,
Early Life Factors, Environmental
Exposures, and Atopy
Results of univariate analyses among
participants with complete and incomplete
data are shown in Tables E4 and E5. Table
E6 shows results of multivariable logistic
regressionmodels weighted for the probability
of each individual belonging to each
phenotype, using the never/infrequent wheeze
as the reference. Males had a higher risk of
developing the three early onset phenotypes,
but not late-onset wheezing. Maternal asthma
was associated with all four phenotypes, with
the strongest association with persistent
wheezing (RRR, 3.12; 95% CI, 2.5123.89;
P, 0.0001). Compared with never/
infrequent wheeze, all wheezing phenotypes
except early onset preschool remitting wheeze,
showed signiﬁcant associations with maternal
smoking during pregnancy. There was little
evidence of association between wheeze
phenotypes and pet ownership or paternal
smoking. Paternal asthma was signiﬁcantly
associated with persistent wheeze in both
genders, but was a predictor of late-onset
wheeze in males only (see Table E4).
The strongest association with allergic
sensitization (ages 4–7.5 yr) was observed
for persistent wheeze (RRR, 5.12; 95% CI,
4.0426.47; P, 0.0001). Two early onset
remitting classes differed substantially in
their association with sensitization: there
was little evidence of association between
sensitization and preschool remitting
wheeze, but clear evidence of an association
between sensitization and midchildhood
remitting wheeze (RRR, 1.61; 95% CI, 1.24–
2.11; P, 0.0001).
Asthma and Lung Function
Associations of wheeze phenotypes with
current asthma and asthma medication use
at the last follow-up are shown in Table 2.
Compared with never/infrequent wheeze, all
four wheeze phenotypes were associated
with higher asthma prevalence. This
association was weakest for early onset
preschool remitting wheeze (RRR, 2.28; 95%
CI, 1.76–2.96 P, 0.0001) and strongest for
persistent wheeze (RRR, 56.54; 95% CI,
43.75–73.06; P, 0.0001). We obtained
similar results in the analysis of 8,223
children with incomplete reports of
wheezing (excluding 7,719 children with
complete reports at ﬁve time points) (see
Table E7). Characteristics of children with
complete report of wheeze and those with
missing data are shown in Table E8.
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Associations of wheeze phenotypes
with lung function in middle childhood
(8.5–11 yr) are shown in Table 3. FEV1
and FEV1/FVC were signiﬁcantly lower
in all wheeze phenotypes compared with
never/infrequent class. Association was
particularly strong for persistent wheeze
(z scores 20.60; 95% CI, 20.70 to 20.50;
P, 0.0001). There was no evidence of
differences in FVC.
Individual Variation within and across
Wheezing Phenotypes
Figure 3 shows the presence/absence of
wheeze at ﬁve time periods among each
individual across latent classes, stratiﬁed by
Table 1. Per cohort and combined characteristics of children with complete reports of wheezing
Most Likely Wheezing Phenotypes
Never/Infrequent
Wheeze
Early Onset
Preschool
Remitting
Early Onset
Midchildhood
Remitting
Persistent Late
Onset
SEATON, n (%) 499 305 (61) 108 (22) 16 (3) 31 (6) 39 (8)
ALSPAC, n (%) 5,149 3,119 (61) 1,058 (20) 476 (9) 253 (5) 243 (5)
MAAS, n (%) 667 421 (63) 96 (14) 34 (5) 84 (13) 32 (5)
Ashford, n (%) 492 233 (47) 176 (36) 28 (6) 50 (10) 5 (1)
IOW, n (%) 912 548 (60) 46 (5) 37 (4) 66 (7) 215 (24)
5-Cohort data, n (%) 7,719 4,626 (60) 1,484 (19) 591 (8) 484 (6) 534 (7)
Sex Male, n (%) 3,881 (50) 2,162 (47) 830 (56) 343 (58) 288 (60) 258 (48)
Birth weight, kg Mean (SD) 3.44 (0.53) 3.44 (0.51) 3.46 (0.54) 3.41 (0.58) 3.48 (0.57) 3.43 (0.52)
Low birth weight (<2.5) Yes, n (%) 314 (4.1) 161 (3) 63 (4) 36 (6) 31 (6) 23 (4)
Maternal age Mean (SD) 29.1 (4.64) 29.2 (4.57) 28.9 (4.58) 28.8 (4.73) 28.7 (4.78) 28.8 (5.07)
Advanced maternal
age (>35)
Yes, n (%) 947 (12) 572 (13) 177 (12) 72 (12) 53 (11) 73 (14)
Maternal smoking Yes, n (%) 6,491 (16) 647 (14) 249 (17) 117 (20) 88 (18) 97 (18)
Paternal smoking Yes, n (%) 1,702 (27) 979 (26) 306 (25) 144 (31) 132 (32) 141 (29)
Pet ownership Yes, n (%) 4,149 (54) 2,449 (54) 818 (56) 334 (58) 264 (55) 284 (54)
Sensitization (midchildhood) Yes, n (%) 1,042 (17) 461 (13) 134 (12) 106 (23) 181 (47) 160 (39)
Current asthma (last
follow-up)
Yes, n (%) 1,000 (14) 121 (3) 113 (8) 86 (15) 352 (75) 328 (67)
Asthma ever Yes, n (%) 1,737 (26) 452 (11) 291 (24) 274 (59) 374 (91) 346 (72)
Asthma medication (last
follow-up)
Yes, n (%) 949 (13) 120 (3) 113 (8) 87 (15) 345 (73) 284 (58)
Asthma medication ever Yes, n (%) 2,125 (42) 591 (14) 294 (20) 374 (64) 451 (93) 415 (89)
Definition of abbreviations: ALSPAC = Avon Longitudinal Study of Parents and Children; IOW= Isle ofWight; MAAS =Manchester Asthma and Allergy Study;
SD = standard deviation; SEATON= Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition study.
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cohort and class membership certainty.
More than 80% of children in never/
infrequent and persistent wheeze classes
were assigned with a high degree of certainty
(membership probability .0.80), whereas
class membership certainty was the lowest
for late-onset wheeze, with 51% of its
members having posterior probabilities
less than 0.80. Sorting individuals in the
vertical space and stratifying them by class
assignment probability revealed fairly
consistent between-individual patterns
when assignment probability was greater
than or equal to 0.80, but heterogeneity
increased as assignment became less certain
(,0.80). Individual wheezing patterns were
particularly heterogeneous in late-onset
wheeze, whereby participants reported
wheezing only once, up to three times
persistently, or intermittently. Of 113
children who were assigned to the early
onset preschool remitting class, but reported
current asthma at the last follow-up, 78
(69%) reported wheezing at later time
points.
Over a tenth of individuals (913/7,719;
12%) had low posterior probabilities
(,0.60) of membership to any class
(Figure 3). Figure E2 shows a heat map of
each individual’s posterior class
membership probabilities, lying between
0 (low) and 1 (high). Inspection of the ﬁgure
reveals that there are individuals whose
patterns do not ﬁt well within the assigned
phenotype (e.g., some have z0.40
probability of belonging to never/infrequent
wheeze and z0.40 probability of belonging
to early onset preschool remitting wheeze).
Discussion
By jointly modeling data on parent/self-
reported wheezing from birth to adolescence
in ﬁve population-based birth cohorts, we
identiﬁed ﬁve distinct phenotypes. In
addition to never/infrequent wheezing, the
latent structure of wheezing disorders from
infancy to adolescence comprised two
persisting (early onset and late-onset) and
two remitting (preschool remitting and
midchildhood remitting) phenotypes. The
model assigned 33% of children to remitting
(24% remitting in preschool, and 9% in
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Figure 2. (A) Transition of most likely membership class between latent models constructed with complete (n = 7,719) and incomplete (n = 15,942) data.
(B) Assignment of children into wheeze phenotypes over a sequence of latent class analysis models with four and five classes based on most likely
membership class. Ellipse nodes show class membership (most likely phenotype), whereas the values along the arrow represent the percentage of children
moving from one class to another. This figure reflects whether themembers of distinct wheeze phenotypes will remain in the same group or shift into another.
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midchildhood), and 15% to persisting
phenotypes (7.9% with onset in early life,
and 7.1% with onset in later childhood). By
pooling the cohorts and restricting our
analyses to participants with complete data,
we obtained a better representation of the
latent structure, while maintaining the
power to detect less prevalent phenotypes
and making meaningful analyses of their
associations with risk factors and outcomes.
This allowed us to determine that an
obstructive pattern of lung function, with
signiﬁcantly diminished FEV1 and
FEV1/FVC, was a feature of all four
wheeze phenotypes. Differing
associations between wheeze phenotypes
and asthma in adolescence conﬁrmed the
validity of derived phenotypes.
To our knowledge, this is the ﬁrst
study to investigate the nature of within-
phenotype heterogeneity by looking at
individual patterns of wheeze within
different thresholds of class assignment. In
the context of wheeze phenotyping, data-
driven techniques, such as LCA, have been
used to discover subgroups within the
study population, which were presumed
to be homogeneous. However, we have
demonstrated that this may not always be
the case. A consistent ﬁnding across all ﬁve
cohorts was that a substantial number of
children were classiﬁed imprecisely and did
not follow wheeze patterns suggested by
the label ascribed to the class when the
individual’s likelihood of belonging to the
assigned class was less than 0.80. Moreover,
the precision with which children were
assigned to a “label” varied across
different classes. The greatest level of
uncertainty in assignment was for the late-
onset class. This within-class heterogeneity
may, in part, be responsible for a lack
of consistent associations of phenotypes
with risk factors reported in previous
studies (22).
Table 2. Adjusted associations of wheezing phenotypes with late outcomes including current asthma, asthma ever, current use of
asthma medication, asthma medication ever, and eczema ever using weighted membership probabilities
Adjusted Odds Ratio (95% Cl)*
Current† Asthma Asthma Ever Current† Asthma
Medication
Asthma
Medication Ever
Eczema
Ever
Never/infrequent Reference Reference Reference Reference Reference
Early onset preschool remitting 2.34 2.05 2.35 1.36 1.24
95% Cl 1.73 to 3.17 1.70 to 2.46 1.74 to 3.18 1.14 to 1.62 1.07 to 1.42
P value ,0.0001 ,0.0001 ,0.0001 0.001 0.003
Early onset midchildhood remitting 3.65 6.41 3.53 5.97 1.31
95% Cl 2.55 to 5.21 5.11 to 8.03 2.47 to 5.05 4.85 to 7.35 1.06 to 1.61
P value ,0.0001 ,0.0001 ,0.0001 ,0.0001 0.010
Persistent 48.31 37.95 42.45 38.67 3.22
95% Cl 35.87 to 65.07 27.78 to 51.84 31.57 to 57.09 28.27 to 52.90 2.55 to 4.08
P value ,0.0001 ,0.0001 ,0.0001 ,0.0001 ,0.0001
Late onset 36.39 12.00 24.51 17.75 2.03
95% Cl 26.89 to 49.25 9.41 to 15.31 18.07 to 33.23 13.59 to 23.17 1.62 to 2.53
P value ,0.0001 ,0.0001 ,0.0001 ,0.0001 ,0.0001
Definition of abbreviations: ALSPAC = Avon Longitudinal Study of Parents and Children; CI = confidence interval; IOW = Isle of Wight; MAAS =Manchester
Asthma and Allergy Study; SEATON= Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition Study.
*Adjusted for sensitization (midchildhood), sex, maternal history of asthma or allergy, maternal smoking, and low birth weight.
†Available at the latest follow-up (e.g., 18 yr in IOW, 16 yr in MAAS, 15 yr in SEATON, 15 yr in Ashford, and 14 yr in ALSPAC).
Table 3. Associations of wheezing phenotypes with lung function measures adjusted for sex, height, and gender using weighted
membership probabilities
Mean Difference (95% Cl)* P value
z Scores for FEV1
† z Scores for FVC† z Scores for FEV1/FVC
†
Never/infrequent Reference Reference Reference
Early onset preschool remitting 20.11 (20.17 to 20.04) 20.05 (20.12 to 0.02) 20.09 (20.16 to 20.02)
0.002 0.144 0.001
Early onset midchildhood remitting 20.19 (20.28 to 20.09) 20.03 (20.13 to 0.06) 20.26 (20.35 to 20.16)
,0.0001 0.531 ,0.0001
Persistent 20.34 (20.44 to 20.24) 0.03 (20.07 to 0.13) 20.60 (20.70 to 20.50)
,0.0001 0.577 ,0.0001
Late onset 20.22 (20.32 to 20.12) 20.04 (20.14 to 0.06) 20.30 (20.40 to 20.20)
,0.0001 0.406 ,0.0001
Definition of abbreviations: CI = confidence interval; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity.
*Adjusted for maternal history of asthma or allergy, maternal smoking, and low birth weight.
†Sex-, age-, and height-adjusted standard deviation units.
ORIGINAL RESEARCH
Oksel, Granell, Haider, et al.: Distinguishing Wheezing Phenotypes 873
One limitation of this multicohort
study is the heterogeneity between cohorts
that were integrated retrospectively (e.g., in
recruitment criteria, data collection time
and intervals, question types and wording,
and tools for collecting data). We observed
some level of variation in the proportion of
children allocated to each phenotype in
different cohorts. For example, ASHFORD
had the lowest prevalence of late-onset
wheeze and highest prevalence of early onset
remitting wheeze, whereas IOW had the
lowest prevalence of early onset preschool
remitting wheeze and the highest prevalence
for late-onset wheeze. We addressed this
limitation by including “cohort site” as a
covariate for determining phenotypes.
One of the advantages of our
multicohort approach is that individual
studies that might not provide conclusive
evidence to make inference about the
general population because of cohort-
speciﬁc effects and biases can contribute to
revealing a more accurate picture when
integrated together. The integration of ﬁve
cohorts and their pooled analysis enhanced
the credibility and generalizability of the
phenotyping results to the U.K. population.
A further advantage is to minimize the
study-speciﬁc biases (including cohort-
speciﬁc effects, attrition effects, different
recruitment strategies, and geographic
factors) affecting the certainty of allocation
of individuals to each latent class, while
maximizing the beneﬁts of individual cohort
studies (e.g., potentially important risk
factors and outcomes are captured in some,
but not all cohorts). Another strength of
pooling cohort data is that a multicohort
design allowed us to analyze a large sample
with complete data on wheeze from birth to
adolescence, thus increasing statistical
power to detect less prevalent phenotypes.
Several birth cohorts have investigated
wheeze phenotypes in childhood (1–4,
10–12, 16, 23–26). The number of derived
phenotypes varied by study, with four
common classes identiﬁed in all cohorts:
never/infrequent wheeze, transient-early,
late-onset, and persistent wheeze. In our joint
analysis, a four-class solution identiﬁed the
same classes, whereas the optimum solution
included a ﬁfth phenotype, early onset
midchildhood remitting wheeze, which was
previously observed in ALSPAC (3, 12, 16)
but not in another independent cohort (3).
School-age onset persisting wheeze that was
previously identiﬁed as a sixth phenotype in
ALSPAC (12, 16) was not detected in our
joint analysis. One possible explanation could
be that we have focused on common ages that
are approximately shared across all cohorts to
ensure compatibility, resulting in the
exclusion of potentially informative time
points for identifying additional phenotypes
(8). An alternative explanation is that some
phenotypes may arise as an artifact of the
analysis (e.g., caused by the increasing data
collection frequency).
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Figure 3. Presence/absence of wheeze at five time periods across latent classes stratified by cohort and class membership probabilities that have been
derived by including cohort site as a covariate. Al = Avon Longitudinal Study of Parents and Children; As = Ashford; I = Isle of Wight; M =Manchester Asthma
and Allergy Study; S = Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition Study; TP = time period.
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When using 15,941 children with at
least two observations of wheeze, individual
allocation to persistent and never/infrequent
phenotypes was consistent with the analysis
using 7,719 complete cases, but there was a
considerable transition in other classes (e.g.,
almost 40% of children in early onset
midchildhood remitting class from
complete data switched to persistent
wheeze). This ﬁnding raises questions about
the conﬁdence with which allocation to early
onset remitting classes can be applied in
cohorts with considerable missing data.
The analyses to understand how children’s
class allocations changed from one
phenotype to another in models with
increasing number of classes have shown
that when moving from a four- to ﬁve-class
solution, transient early wheeze was
divided into two remitting classes.
Preschool remitting phenotype included
children who were assigned to transient early
and never/infrequent wheeze, whereas
midchildhood remitting phenotype was
formed by children assigned to transient early
and persistent wheeze in a four-class model.
These newly formed remitting phenotypes
showed different associations with risk
factors, lung function, and later asthma,
suggesting that they may be distinct entities,
or that phenotype allocation also reﬂects
wheeze severity.
We have extended previous
observations of the association between
persistent and late-onset wheezing with
allergic sensitization (1), by demonstrating
that two early onset remitting classes
differed in their association with
sensitization: there was little evidence
of association between sensitization
and preschool remitting wheeze, but
sensitization was strongly associated with
midchildhood remitting wheeze. This
suggests that some transient wheezers may
have longer wheeze duration in association
with the development of sensitization. Most
previous studies have shown that lung
function is impaired in some, but not all
wheeze phenotypes (11, 23, 24). In our
study, all wheeze phenotypes were
associated with diminished lung function
compared with never/infrequent wheeze,
with the greatest impairment in persistent
wheeze. This is particularly important in the
context of ﬁndings that low FEV1 at its
physiologic plateau in early adult age is
important in the genesis of chronic
obstructive pulmonary disease (27) and
early cardiovascular mortality (28). Several
recent studies have shown that low
childhood lung function trajectory is
associated with future chronic obstructive
pulmonary disease risk (29–31), and our
ﬁndings of impaired lung function in
school age across all childhood wheezing
phenotypes suggest that the notion that
episodic wheeze in early life has a benign
long-term prognosis may not be true for a
proportion of transient wheezers.
It is often stated that temporal analyses
may be crucial for distinguishing between
different endotypes of asthma (6), and that
derived latent classes (“phenotypes”) may be
used to improve discovery process in genetic
and environmental studies (5). However, to
date, there has been a lack of consistency in
associations between wheeze phenotypes
and genetic and environmental factors, and
a scarcity of information on temporal
characteristics of individual proﬁles of
symptoms within the longitudinal latent
classes. Our ﬁndings suggest that one of the
reasons for the inconsistencies may be
because associations are diluted due to
within-phenotype heterogeneity. We
observed considerable within-class
heterogeneity in wheezing patterns, which
increased as the assignment became less
certain. Individual wheezing patterns were
particularly heterogeneous in the late-onset
wheeze. It is also of note that a proportion of
children in the early onset preschool
remitting class reported wheezing at later
time points. This can explain the increased
risk of asthma in transient wheezers,
because approximately 70% of individuals
with later-life asthma within this class
reported wheezing beyond age 10.
In conclusion, our results suggest that
early life episodic wheeze may not have a
benign prognosis for a proportion of
transient wheezers. Up to 12% of children
have low membership probability of any
wheezing phenotype, and the mere presence
or absence of a wheeze may be insufﬁcient to
derive homogenous phenotypes for probing
causality. It is likely that more holistic
indicators of wheeze (including frequency
and severity) are needed to describe
individual trajectories and derive more
homogenous phenotypes to facilitate better
understanding of the natural history and
causality of childhood wheezing illness. n
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